Glycogen storage disease type II cost-effectiveness of therapy: Revision history

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

19 July 2016

20 September 2012

  • curprev 02:2002:20, 20 September 2012‎ Shankar Kumar talk contribs‎ 696 bytes +696‎ Created page with "__NOTOC__ {{Glycogen storage disease type II}} {{CMG}} ==Overview== ==Cost-Effectiveness of Therapy== Myozyme costs an average of $300,000 a year, and must be taken for the pa..."
Retrieved from "https://www.wikidoc.org/index.php/Glycogen_storage_disease_type_II_cost-effectiveness_of_therapy"